← The Wire
NGENNasdaq
NERVGEN PHARMA CORP.
Pharmaceutical Preparations · A1 · CIK 1751912
Develops neuroreparative therapeutics for spinal cord injury and other neurologic conditions
$204M
Market cap
$1.96
Last close
+4.8%
1D
-8.4%
5D
806K
Volume
Price · last 39 sessions-46.4%
May 4L $1.73 · H $3.89Jun 29
10
Total filings
Jun 1, 2026
Last filing
12/31
Fiscal year end
6-KFORM 6-KJun 1, 20266-KFORM 6-KMay 26, 20266-KFORM 6-KMay 22, 20266-KFORM 6-KMay 18, 20266-KFORM 6-KMay 15, 20266-KFORM 6-KApr 27, 20266-KFORM 6-KMar 13, 20266-KFORM 6-KFeb 13, 20266-KFORM 6-KFeb 10, 20266-KFORM 6-KJan 8, 2026
Similar companies
Comparable business profile · signals at a glance